Track the 알테오젠 share price and the full management transaction log of the company, a publicly traded company based in South Korea. Shares trade on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 알테오젠 has recorded 2 public disclosures. Market capitalisation: €18,032.9bn. The latest transaction was reported on 7 April 2026 (Sale). Among the most active insiders: 박순재. The full history is free.
Analysts rate 알테오젠 Buy (bullish), based on 5 analysts. Average price target: ₩458,000.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.